SCHEMBL30830765

SCHEMBL30830765

Oc1ccc(F)c(-c2ccc(OCc3ccccc3)nc2OCc2ccccc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGER1 P34995 1/20 0.43
▸ GRM5 P41594 2/20 0.40
▸ MCL1 Q07820 1/20 0.40
▸ BAK1 Q16611 1/20 0.40
▸ LMNA P02545 2/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ SLC6A2 P23975 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ PTGS2 P35354 1/20 0.39
▸ SLC6A3 Q01959 1/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ SQOR Q9Y6N5 1/20 0.37
▸ MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30830994 0.89 MAOB (0.40) PTGER1GRM5LMNACYP1A2L3MBTL1
SCHEMBL25254252 0.85 PTGER1 (0.62) PTGER1MCL1BAK1
SCHEMBL30158160 0.85 PTGER1 (0.62) PTGER1MCL1BAK1
SCHEMBL30830608 0.85 MCL1 (0.47) GRM5MCL1BAK1LMNACYP1A2
SCHEMBL26172139 0.83 GRM5 (0.41) GRM5MCL1BAK1LMNACYP1A2
SCHEMBL30830801 0.83 MCL1 (0.48) GRM5MCL1BAK1LMNACYP1A2
SCHEMBL30427588 0.83 MAOA (0.44) PTGER1GRM5MCL1BAK1CYP1A2
SCHEMBL25191988 0.83 MAOA (0.44) PTGER1GRM5MCL1BAK1CYP1A2
SCHEMBL25198407 0.82 CNR1 (0.43) GRM5MCL1BAK1L3MBTL1KDM4E
SCHEMBL24881044 0.81 NUDT1 (0.40) GRM5LMNACYP1A2CYP2C19L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 — — EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 — — WO disclosed
Send feedback